1
|
Lepechkin-Zilbermintz V, Bareket D, Gonnord V, Steffen A, Morice C, Michaut M, Munder A, Korshin EE, Contreras JM, Cerasi E, Sasson S, Gruzman A. Moderately lipophilic 2-(Het)aryl-6-dithioacetals, 2-phenyl-1,4-benzodioxane-6-dithioacetals and 2-phenylbenzofuran-5-dithioacetals: Synthesis and primary evaluation as potential antidiabetic AMPK-activators. Bioorg Med Chem 2023; 87:117303. [PMID: 37167713 DOI: 10.1016/j.bmc.2023.117303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Revised: 04/24/2023] [Accepted: 04/26/2023] [Indexed: 05/13/2023]
Abstract
Since the 1950's, AMP-kinase (AMPK) has been used as a promising target for the development of antidiabetic drugs against Type 2 diabetes mellitus (T2D). Indeed, the canonical antidiabetic drug metformin recruits, at least partially, AMPK activation for its therapeutic effect. Herein we present design and synthesis of 20 novel relatively polar cyclic and acyclic dithioacetals of 2-(Het)arylchroman-6-carbaldehydes, 2-phenyl-1,4-benzodioxane-6-carbaldehyde, and 2-phenylbenzofuran-5-carbaldehyde, which were developed as potential AMPK activators. Three of the synthesized dithioacetals demonstrated significant enhancement (≥70%) of glucose uptake in rat L6 myotubes. Noteworthy, one of the dithioacetals, namely 4-(6-(1,3-dithian-2-yl)chroman-2-yl)pyridine, exhibited high potency comparing to other molecules. It increased the rate of glucose uptake in rat L6 myotubes and augmented insulin secretion from rat INS-1E cells in pharmacological relevant concentrations (up to 2 μM). Both effects were mediated by activation of AMPK. In addition, the compound showed excellent pharmacokinetic profile in healthy mice, including maximal oral bioavailability. Such bifunctionality (increased glucose uptake and insulin secretion) can be used as a starting point for the development of a novel class of antidiabetic drugs with dual activity that is relevant for T2D treatment.
Collapse
Affiliation(s)
| | - Daniel Bareket
- Department of Pharmacology, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, 91120, Jerusalem, Israel
| | - Virginie Gonnord
- PRESTWICK CHEMICAL, 220 Boulevard Gonthier d'Andernach, 67400 Illkirch, France
| | - Alexandre Steffen
- PRESTWICK CHEMICAL, 220 Boulevard Gonthier d'Andernach, 67400 Illkirch, France
| | - Christophe Morice
- PRESTWICK CHEMICAL, 220 Boulevard Gonthier d'Andernach, 67400 Illkirch, France
| | - Mathieu Michaut
- PRESTWICK CHEMICAL, 220 Boulevard Gonthier d'Andernach, 67400 Illkirch, France
| | - Anna Munder
- RECIPHARM Israel Ltd., 9 Hamzamara Str., 7404709, Nes Ziona, Israel
| | - Edward E Korshin
- Department of Chemistry, Faculty of Exact Sciences, Bar-Ilan University, 52900, Ramat-Gan, Israel
| | | | - Erol Cerasi
- The Endocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel
| | - Shlomo Sasson
- Department of Pharmacology, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, 91120, Jerusalem, Israel
| | - Arie Gruzman
- Department of Chemistry, Faculty of Exact Sciences, Bar-Ilan University, 52900, Ramat-Gan, Israel.
| |
Collapse
|
3
|
Affiliation(s)
- Ameen A. Abu-Hashem
- a Photochemistry Department (Heterocyclic Unit) , National Research Center , Giza , Egypt
- b Chemistry Department, Faculty of Science , Jazan University , Jazan , Saudi Arabia
| | - Hoda A. R. Hussein
- a Photochemistry Department (Heterocyclic Unit) , National Research Center , Giza , Egypt
| | - Ahmed S. Aly
- a Photochemistry Department (Heterocyclic Unit) , National Research Center , Giza , Egypt
| | - Moustafa A. Gouda
- c Chemistry Department, Faculty of Science , Mansoura University , Mansoura , Egypt
- d Chemistry Department, Faculty of Science and Arts , Taibah University , Ulla , Saudi Arabia
| |
Collapse
|
4
|
Yow S, Nako AE, Neveu L, White AJP, Crimmin MR. A Highly Chemoselective, Zr-Catalyzed C–O Bond Functionalization of Benzofuran. Organometallics 2013. [DOI: 10.1021/om4008295] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Affiliation(s)
- Shuhui Yow
- Department
of Chemistry, Imperial College London, London SW7 2AZ, United Kingdom
| | - Adi E. Nako
- Department
of Chemistry, Imperial College London, London SW7 2AZ, United Kingdom
| | - Léonard Neveu
- Department
of Chemistry, Imperial College London, London SW7 2AZ, United Kingdom
| | - Andrew J. P. White
- Department
of Chemistry, Imperial College London, London SW7 2AZ, United Kingdom
| | - Mark R. Crimmin
- Department
of Chemistry, Imperial College London, London SW7 2AZ, United Kingdom
| |
Collapse
|
5
|
Chiba H, Sakai Y, Oishi S, Fujii N, Ohno H. Lewis-acid-mediated ring-exchange reaction of dihydrobenzofurans and its application to the formal total synthesis of (−)-quinocarcinamide. Tetrahedron Lett 2012. [DOI: 10.1016/j.tetlet.2012.09.030] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Yoshida S, Kasai M, Kimura T, Akiba T, Takahashi T, Sakamoto S. Development of a Practical and Scalable Synthesis of a Potent Selective Dual Antagonist for 5-HT2B and 5-HT7 Receptors. Org Process Res Dev 2012. [DOI: 10.1021/op200380z] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Shinya Yoshida
- Process Chemistry Laboratories, Astellas Pharma Inc., 160-2 Akahama, Takahagi-shi,
Ibaraki 318-0001, Japan
| | - Makoto Kasai
- Process Chemistry Laboratories, Astellas Pharma Inc., 160-2 Akahama, Takahagi-shi,
Ibaraki 318-0001, Japan
| | - Takenori Kimura
- Astellas Research Technologies Co., Ltd., 21 Miyukigaoka, Tsukuba-shi,
Ibaraki 305-8585, Japan
| | - Takahiro Akiba
- Process Chemistry Laboratories, Astellas Pharma Inc., 160-2 Akahama, Takahagi-shi,
Ibaraki 318-0001, Japan
| | - Takumi Takahashi
- Process Chemistry Laboratories, Astellas Pharma Inc., 160-2 Akahama, Takahagi-shi,
Ibaraki 318-0001, Japan
| | - Shuichi Sakamoto
- Astellas Pharma Europe B.V., Elisabethhof 19, 2353 EW Leiderdorp, The Netherlands
| |
Collapse
|
7
|
Nador F, Moglie Y, Vitale C, Yus M, Alonso F, Radivoy G. Reduction of polycyclic aromatic hydrocarbons promoted by cobalt or manganese nanoparticles. Tetrahedron 2010. [DOI: 10.1016/j.tet.2010.04.026] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Barluenga J, Fañanás FJ, Sanz R, Marcos C. Intramolecular Carbolithiation of Allylo-Lithioaryl Ethers: A New Enantioselective Synthesis of Functionalized 2,3-Dihydrobenzofurans. Chemistry 2005; 11:5397-407. [PMID: 16003808 DOI: 10.1002/chem.200500377] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
A new and easy method for the diastereoselective synthesis of 3-functionalized 2,3-dihydrobenzofuran derivatives from allyl 2-bromoaryl ethers is described. The key step of this transformation involves an intramolecular carbolithiation reaction of allyl 2-lithioaryl ethers. The substituents in both the allyl and the aryl moieties play an important and decisive role in stopping the reaction at the benzofuran thus avoiding a gamma-elimination reaction. Finally, this process is amenable to the synthesis of enantiomerically enriched compounds by using (-)-sparteine as a chiral inductor.
Collapse
Affiliation(s)
- José Barluenga
- Instituto Universitario de Química Organometálica Enrique Moles, Unidad Asociada al C.S.I.C., Universidad de Oviedo, Julián Clavería 8, 33006-Oviedo, Spain.
| | | | | | | |
Collapse
|